An uncontrolled GPB phenotype-based study of four different ethnic groups in Colombia, suggested an association between the GPB S−s+ variant and a greater resistance to malaria (P. vivax and/or P. falciparum) in people of African origin [48]. This evidence concerns the gene GYPB and malaria.